REPAIR AND REGENERATION IN THE CORNEAL STROMA
REPAIR AND REGENERATION IN THE CORNEAL STROMA
批准号:
7474586
负责人:
M. Elizabeth Fini
金额:
$39.94万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-12-01 至 2012-07-31
关键词:
AddressAdultBasement membraneCellsChronicClinicalCorneaCorneal StromaCrystallinsCultured CellsDepositionEmbryonic DevelopmentEpithelialEpithelial CellsEyeFamilyFibroblast Growth Factor 2FibroblastsFibrosisGatekeepingGoalsGrowth FactorHumanInjuryInterventionLeftLightLocalizedMediatingMediator of activation proteinModelingModificationMolecularMolecular TargetMusMyofibroblastNatural regenerationOperative Surgical ProceduresOrganOryctolagus cuniculusOutcomePathway interactionsPhenotypePlatelet-Derived Growth FactorProcessProductionProtein IsoformsProteinsQuality ControlResearchResearch PersonnelRetinaShapesSignal PathwaySignal TransductionTechniquesTimeTissuesTransforming Growth Factor Beta 2Transforming Growth Factor betaTransketolaseWorkWound Healingbaseclinical applicationcorneal epitheliumcorneal repaircytokinedesignfollow-upimprovedinsightmouse modelprogramsprotein degradationrepairedresearch studyresponsewound
中文摘要
描述(由申请人提供):角膜将光线聚焦在视网膜上,提供眼睛三分之二以上的屈光力。为了实现这一功能,它必须是完全透明的,并且必须具有在胚胎发育期间实现的精确形状。成人角膜似乎有多种机制,让一个好的东西足够单独,一组现象,我们在当前的项目期间定义为“角膜恒常性”。当角膜的损伤足够广泛时,可以克服角膜的恒定性,并增强修复反应。角膜修复的质量存在于一个光谱上,一端的过程几乎完全再生,而另一端是纤维化修复。在角膜中,纤维化产生混浊,并且纤维化修复组织的收缩改变角膜形状。这些效应不期望地影响了将光反射到视网膜上的能力。该项目的长期目标是提高我们对角膜停滞、修复反应和赋予再生特征的机制的理解。在过去的十年中,该研究小组和其他人已经开发了一种纤维化进展模型,作为两步过程,当角膜细胞被“激活”时开始,假设“成纤维细胞”表型,其可以进展为与纤维化修复相关的“肌成纤维细胞”表型。也已经获得了一些决定激活和进展的分子机制的见解。此外,该实验室小组已经确定了角膜修复和血管化组织修复之间的重要差异。在新的项目期间,该小组建议以临床应用为目标,跟进其中一些关键发现。这两个目标解决了以下问题:1)角膜细胞活化和角膜晶体转酮醇酶损失的机制,这对细胞透明度很重要; 2)向纤维化的转变和角膜上皮基底膜决定纤维化调节因子TGF-β 2释放的机制。目前,角膜屈光矫正围绕着日益精细的手术技术来限制伤口修复反应的量。然而,可以认为,通过控制修复的质量也可以改善手术结果。该小组将重点关注的问题,承诺提供新的洞察分子靶点的药物干预。
英文摘要
DESCRIPTION (provided by applicant): The cornea focuses light on the retina, providing more than two thirds the refractive power of the eye. To perform this function, it must be completely transparent, and it must have a precise shape, achieved during embryonic development. The adult cornea appears to have multiple mechanisms for leaving a good thing well enough alone, a group of phenomena we defined in the current project period as "corneal constancy". When damage to the cornea is extensive enough, corneal constancy can be overcome, and a repair response ensues. The quality of repair in the cornea exists on a spectrum, with the process at one end being almost completely regenerative while at the opposite end is fibrotic repair. In the cornea, fibrosis creates opacity, and the contraction of fibrotic repair tissue alters corneal shape. These effects impinge undesirably on the capacity to refract light on the retina. The long-term goal of this project is to improve our understanding of corneal stasis, the repair response, and the mechanisms that confer regenerative character. Over the past decade, this research group and others have developed a model for fibrotic progression as a two step process that begins when keratocytes are "activated", assuming a "fibroblast" phenotype, which can progress to the "myofibroblast" phenotype associated with fibrotic repair. Insight has also been acquired into some of the molecular mechanisms determining activation and progression. Moreover, this lab group has identified important differences between corneal repair and repair in vascularized tissues. In the new project period, the group proposes to follow up on some of these key findings with the goal of clinical application. The two aims address the following: 1) keratocyte activation and the mechanisms for loss of the corneal crystalline transketolase, important for cell transparency; 2) transition to fibrosis and the mechanism whereby the corneal epithelial basement membrane determines release of the fibrotic regulator TGF-beta2. At the present time, corneal refractive correction revolves around the increasing refinement of surgical technique to limit the quantity of the wound repair response. However, it could be argued that surgical outcomes might also be improved by controlling the quality of repair. The group will focus on questions that promise to provide new insight into molecular targets for pharmacologic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondria and Mustard Damage at the Ocular Surface
-
批准号:10708498
-
项目类别:
-
资助金额:$53.74万
-
财政年份:2023
-
负责人:M. Elizabeth Fini
-
依托单位:
Dynasore Analogues for Ocular Surface Protection
-
批准号:10310762
-
项目类别:
-
资助金额:$10.87万
-
财政年份:2019
-
负责人:M. Elizabeth Fini
-
依托单位:
Dynasore Analogues for Ocular Surface Protection
-
批准号:10004039
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2019
-
负责人:M. Elizabeth Fini
-
依托单位:
Protection and Treatment of the Ocular Surface Barrier
-
批准号:9334035
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9921393
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9333672
-
项目类别:
-
资助金额:$59.65万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9751867
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9329433
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9196261
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9755442
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:6888034
-
项目类别:
-
资助金额:$58.36万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
CORE--EQUIPMENT
-
批准号:6985840
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
AFMINISTRATION
-
批准号:6985838
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:6797085
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:7061202
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Supplement to Core Grant for Vision Research
-
批准号:6494562
-
项目类别:
-
资助金额:$51.14万
-
财政年份:2002
-
负责人:M. Elizabeth Fini
-
依托单位:
Core Grant for Vision Research
-
批准号:6346517
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2001
-
负责人:M. Elizabeth Fini
-
依托单位:
METALLOPROTEINASES AND FAILURE TO RE-EPITHELIALIZE
-
批准号:2082550
-
项目类别:
-
资助金额:$18.71万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
METALLOPROTEINASES AND FAILURE TO RE-EPITHELIALIZE
-
批准号:2082549
-
项目类别:
-
资助金额:$19.16万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
Maintenance of Ocular Surface Integrity
-
批准号:6686925
-
项目类别:
-
资助金额:$30.3万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
海外基金